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Through the lens of the Hispanic Paradox, this thesis examines healthy and
unhealthy life expectancy changes occurring from 1997 to 2015 among Hispanics, nonHispanic blacks, and non-Hispanic whites in the United States. The goal is to determine
how Hispanics –disaggregated by nativity status– fare relative to other racial-ethnic
groups in regard to changes in the percentage of total life expectancy that is lived in a
healthy state (i.e. compression and expansion of morbidity). Using the Sullivan method,
multi-state life tables were created with functional limitation prevalence data from the
National Health Interview Survey. Results indicate that most subpopulation groups
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CHAPTER I
INTRODUCTION
The compression of morbidity hypothesis –positing that healthy life expectancy
and total life expectancy both increase over time– and the expansion of morbidity
hypothesis – positing that healthy life decreases as total life expectancy increases– have
been the subject of much research in public health and health demography literature. This
body of research shows mixed support for these hypotheses occurring over time, being
varied by race, gender, and education level (Cai & Lubitz, 2007; Crimmins & Saito,
2001).
Prior research has also examined race-ethnicity disparities in active, disabilityfree, and disabled life expectancy (Crimmins, Hayward, & Saito, 1996; Hayward &
Heron, 1999; Sole-Auro et al., 2012). Nevertheless, few studies have examined changes
in health expectancies over time among Hispanics in the United States. Prior research on
the Hispanic paradox has also tended to focus on morbidity comparisons during single
periods of time rather than over time. I address this gap by examining recent trends in
total life expectancy (TLE) and disability-free life expectancy (DFLE) by race-ethnicity,
nativity, and gender. Additionally, particular attention is given to non-Hispanic whites,
U.S. born Hispanics, and foreign-born Hispanics.
This study extends previous research on this topic in two ways. First, through the
lens of the Hispanic Paradox (or the idea that Hispanics have health that is on par or even
1

better than whites despite the former’s lower socioeconomic status), I examine these
trends in TLE and DFLE to understand if the Paradox may extend to the occurrence of
morbidity compression or expansion, adding a time element that is largely absent in
previous research into the Hispanic Paradox as it relates to TLE and DFLE. Second, this
research serves as an update to the literature on compression/expansion by race-ethnicity,
nativity and gender. I intend to answer the following questions:

1) Do changes in the percentage of total life expectancy that is lived disabilityfree from 1997-2015 indicate the occurrence of morbidity compression or
expansion for non-Hispanic whites, non-Hispanic blacks, U.S. born Hispanics,
and foreign-born Hispanics disaggregated by gender?
2) Do recent changes in the percentage of total life expectancy that is lived
disability-free vary by gender?
3) Do recent changes in the percentage of total life expectancy that is lived
disability-free among Hispanics vary by nativity status?
4) How do recent changes in the percentage of total life expectancy that is lived
disability-free vary among whites, U.S. born Hispanics, and foreign-born
Hispanics?

2

CHAPTER II
BACKGROUND
Two competing hypotheses explain the interrelationship between morbidity and
mortality over time within a population1. Compression of morbidity occurs when
increases in life expectancy over time are accompanied by a decreased period of
morbidity (Fries, 1980). The logic of this hypothesis is that the improvements in health
leading to increased life expectancy for individuals would also impede chronic disease
onset and lower its incidence. In other words, this explanation suggests that individuals
would live longer lives while experiencing the onset of morbidity at a later point in life.
Alternatively, expansion of morbidity occurs when increases in life expectancy
over time are accompanied by an increased period of morbidity (Gruenberg, 1997;
Olshansky et al. 1990; Olshansky et al. 1991). The underlying premise of this hypothesis
is that by living longer, individuals’ risk of being affected by chronic diseases is raised.
Furthermore, implications exist for those already suffering from chronic disease. If the
onset of disease remained static, increases in life expectancy due to lowered chronic
disease mortality would have those afflicted living longer in their morbid state. In other
words, the expansion of morbidity hypothesis posits that the reduction of chronic disease

1

Though this study is not equipped to examine it, a third hypothesis exists in that of dynamic equilibrium.
This hypothesis suggests that increases in total life expectancy would produce increases in both healthy and
unhealthy life expectancy and a decrease in the severity of morbidity (Manton, 1982).
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mortality through medical advancements would produce an increased period of unhealthy
life expectancy for the population.
Morbidity Trends
Much empirical support exists for the occurrence of morbidity compression in the
U.S. Longitudinal studies in medicine have found support for compression of morbidity
(Vita et al., 1998; Hubert et al., 2002; Wang et al., 2002), though these studies focus on
individual trajectories, making comparisons of morbidity onset and severity among aging
persons with varying levels of risk factors. Demography research, which has tended to
examine population-based trends of morbidity, also shows some support for the
compression of morbidity has also been conducted. Cai and Lubitz (2007) found that
active-life expectancy increased between 1992 and 2002 among older Americans while
disabled-life expectancy decreased. These results support the compression hypothesis.
However, results from other studies vary by gender, race, and educational attainment.
Crimmins and Saito (2001) considered differences in healthy life expectancy by gender
and education for blacks and whites at ages 30 and 65, finding that the occurrence of
compression and morbidity between 1980-1990 varied among the subgroups examined.
For example, compression occurred for older white and black men with higher education,
though expansion of morbidity had occurred for older black females with high education.
Additional research has considered racial differences in healthy life expectancy.
Crimmins et al. (1996) considered racial, gender, and educational differences in active
life expectancy among elderly individuals in the U.S. and found that blacks had a greater
amount of inactive life expectancy when compared to non-blacks across gender and level
of education. Hayward and Heron (1999) found racial/ethnic differences in active life
4

expectancy in the U.S. for whites and other minority groups, including Hispanics; greater
life expectancy was accompanied by less disability for some groups and greater disability
for others. For Hispanics specifically, the percentage of inactive life expectancy was
shorter than that of white and most other racial/ethnic groups in the study (Hayward &
Heron, 1999). Sole-Auro et al. (2012) considered the change in morbidity trends in the
1990s to find that the percent of total life expectancy spent disability-free decreased for
black and white males and females between ages 60-90.
Recent evidence has found evidence that could suggest the occurrence of
morbidity compression or expansion in recent years. Life expectancy has generally
increased among non-Hispanic whites, non-Hispanic blacks, and Hispanics in the United
States from 2006-2014 (Kochanek et al., 2016) 2. Additionally, some evidence suggests
that the prevalence of functional limitations has decreased for the oldest Americans (i.e.
those aged 80+), while those somewhat younger experienced an increase in prevalence
(i.e. those aged 60-69) (Seeman et al., 2010). However, earlier research suggested that
functional limitation prevalence had improved or remained stable in years prior for
middle-aged and older whites, blacks, and Hispanics (Crimmins & Saito, 2000; Cutler,
2001; Freedman & Martin, 1998; Martin et al., 2010). Some of this research has also
suggested greater improvements in functional limitations for men than women (Crimmins
& Saito, 2000; Freedman & Martin, 1998). While these trends are not current and lack
the degree of disaggregation that exists in this present research, morbidity expansion

2

Life expectancy also increased steadily among non-Hispanic whites and blacks prior to 2006, but national
life tables disaggregated by race and Hispanic origin are not available before 2006.
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might have occurred recently if the prevalence of functional limitations has remained
static while life expectancy has continued to increase.
Hispanic Paradox
As of 2014, Hispanics made up a 17.3% share of the U.S. (approximately 55.2
million people), up from 6.5% (approximately 14.8 million people) in 1980 (Pew
Research Center, 2016). This accelerated growth in the Hispanic population is
attributable in part to immigration policy (i.e. Immigration Reform and Control Act) and
increased border control on the U.S./Mexico Border (Massey & Capoferro, 2009). The
former served to discourage the hiring of undocumented workers but also granted
residence to over 3 million persons. The latter made circular migration of temporary
workers from Latin America more difficult. As such, more migrant workers (along with
their families) came to reside in the U.S for longer periods of time or permanently
(Reyes, 2004; Riosmena, 2004). Given the share of the population that Hispanics account
for, it is unsurprising that studies of Hispanic health -and the determinants of such- have
become more prevalent, as well as race-ethnicity comparisons of these. Such studies have
suggested the existence of the Hispanic paradox. First referred to as an “epidemiologic
paradox”, the Hispanic paradox is the idea that Hispanics experience similar or better
mortality and life expectancy than whites (Markides & Coriel, 1986). This is paradoxical
in the sense that Hispanics have socioeconomic status that is lower than that of whites
and more similar to blacks, who are typically worse off in regard to mortality and life
expectancy. A review of the literature on the Hispanic Paradox research generally
suggests that adult Hispanics in the U.S. have advantages in terms of mortality rates
(Markides & Eschbach, 2011). This advantage in mortality is likely attributable to lower
6

disease-specific mortality from cancer, stroke, hypertension, and coronary heart disease
(Franzini et al., 2011; Crespo et al., 1996).
When making comparisons of health outcomes for Hispanics relative to different
race-ethnicity groups (especially non-Hispanic whites), nativity status of the former is
often taken into consideration. Indeed, numerous studies have considered health
differences by nativity status, with most finding that foreign-born Hispanics tended to
have better health outcomes than their U.S. born counterparts (Escarce et al., 2006;
Eschbach et al., 2007; Hummer et al., 2011; Zhang et al., 2012; Cantu et al., 2013;
Lariscy et al., 2014). Some of the disadvantages that U.S. born Hispanics have could be
due, in part, to poor health behaviors, weakened familial and social support, and social
discrimination (Escarce et al., 2006; National Research Council, 2006). In the past, rates
of smoking for U.S. born Hispanics have been higher. More recent data shows that the
same pattern exists has continued to exist (Centers for Disease Control and Prevention,
2015). According to Blue and Fenelon (2011), smoking-related causes of mortality help
to explain the advantages that foreign-born Hispanics have over whites as well, not just
U.S. born Hispanics. Aside from smoking, foreign-born Hispanics have been more likely
to have better nutrition than their U.S. born counterparts (Escarce et al., 2006). The
differences in health behaviors among foreign-born and U.S. born Hispanics can partially
be explained by the process of acculturation, or acquiring the traits and practices of
another culture. Most evidence shows acculturation of Hispanics having a negative
impact on their health behaviors – particularly smoking, substance abuse, nutrition, and
exercise (Lara et al., 2006).

7

The arguments discussed above focus on the protective effects of culture.
However, other explanations argue that the Hispanic paradox is simply the result of
selection or data quality. In regard to selection, the healthy migrant explanation suggests
that the paradox exists because Hispanics who are immigrants to the United States are
those healthy enough to migrate. In other words, the health of the U.S. Hispanic
population is skewed due to the number of healthy migrants entering the country. As one
explanation involving data quality, salmon bias suggests that older Hispanic migrants
leave the U.S. to return to their native country as their health declines. These health issues
and deaths would not be recorded in the U.S., and this would, in turn, produce a healthier
Hispanic population that would otherwise have greater morbidity and/or mortality.
However, evidence has suggested that the effects of salmon bias and the healthy
migration hypothesis do not fully explain the paradox (Abraido-Lanza et al., 1999;
Palloni & Arias, 2004; Riosmena et al., 2013; Turra & Elo, 2008). As another
explanation based on data quality, consideration has also been given to the effects of
racial-ethnic misclassification on the existence of the Hispanic Paradox, as race and
ethnicity for some decedents can be inaccurately coded due to being recorded by persons
(e.g. coroners) who may not actually know the decedent’s race and/or ethnicity.
However, many studies that either use methods to correct for misclassification or
mortality-linked data sources with self-indicated race-ethnicity still find evidence of
Hispanics’ mortality advantage (Arias, 2010; Arias et al., 2010; Elo et al., 2004; Lariscy
et al., 2015; Palloni & Arias, 2004).
As alluded to above, attempts have been made to test if the Hispanic Paradox
extends to disability and functional limitations. Using U.S. Census data from 2000,
8

Markides et al. (2007) found that disability among individuals 65 and older was much
higher for Hispanics than whites. Eschbach et al. (2007) found that foreign-born
Hispanics of Mexican origin had greater life expectancy but a longer period of disability
compared to U.S. born Hispanics. Cantu et al. (2013) found that foreign-born Hispanics
had fewer years lived with functional limitations than whites. U.S. born Hispanics lived
more functionally limited years in comparison to foreign-born counterparts and whites.
This research also suggested that years spent functionally limited were more numerous
for women than men (Cantu et al., 2013). Hayward et al. (2014) found support for the
Hispanic paradox in terms of life expectancy for the elderly U.S. population but not for
the paradox’s extension to disability-free life expectancy when using ADLs (or activities
of daily living) as an indicator of disability. In their study, foreign and U.S. born
Hispanics were disadvantaged in regard to disability when compared to non-Hispanic
whites.
In light of the literature reviewed here, an existing gap in research can be
addressed by examining the percentage of total life expectancy that is lived disability-free
for non-Hispanic whites (henceforth referred to as whites), non-Hispanic blacks
(henceforth referred to as blacks), and Hispanics adults across the life course, while
disaggregating Hispanics by nativity status in the process. To do this, multistate life
tables were created using the Sullivan method and data from the National Health
Interview Survey (NHIS), vital statistics from the National Center for Health Statistics
(NCHS), and the Census Bureau’s Current Population Survey (CPS). Morbidity
compression and/or morbidity expansion may have occurred for different subpopulation
groups here. While I do not expect that one of these outcomes in particular may have
9

occurred instead of another for any specific group, I do expect that the Hispanic paradox
will extend to these morbidity trends. In other words, I expect that foreign-born Hispanics
will have similar, if not better, trends in the percentage of total life expectancy that is
lived disability-free relative to whites, while U.S. born Hispanics should fare worse in
these trends.
This study contributes to scientific research in two ways. In regard to morbidity
compression and expansion literature, it provides updated morbidity trends (i.e. patterns
of change in the percentage of total life expectancy that is lived disability-free) for recent
years and also considers the trends experienced for Hispanics, who are largely absent
from past literature that considers these trends. This study also adds to the Hispanic
paradox literature by considering the paradox’s extension to trends of
compression/expansion. Additionally, the use of a time series is a novel element in this
study, as prior research has focused on comparisons of TLE and DFLE between
Hispanics and whites at a single period in time, rather than examining change over time.

10

CHAPTER III
DATA, MEASURES, AND METHODS
Data
To determine healthy and unhealthy life expectancy using the Sullivan method
(which will be explained below), it is necessary to use both age-specific prevalence rates
and age-specific mortality rates. For the purposes of this paper, data collected from the
NHIS for years 1997-2015 will be used to provide age-specific prevalence data. Allcause mortality data and population counts used to calculate age-specific mortality rates
come from NCHS vital statistics and the CPS, respectively.
The NHIS is a cross-sectional, household survey conducted annually by the
NCHS that contains responses from roughly 40,000 households each year. The NHIS is
nationally-representative of the U.S. civilian, noninstitutionalized population in a given
survey year. The 1997-2015 NHIS Adult Sample file –a subsample of the survey – is
used for this research and will be retrieved from the Integrated Health Interview Series, a
source providing harmonized data from the NHIS. Data collection for the Adult Sample
file began in 1997 with a redesign of the NHIS. As such, the span of years covered by
this present study must begin, at the earliest, in 1997. With the NHIS Adult Sample file, a
single adult is randomly selected from each household surveyed in the NHIS and asked
questions regarding health status, health behaviors, and health care services; survey items

11

asking sampled adults about functional limitations are of key importance for this present
research.
Mortality rates for the life tables are constructed using U.S. Vital statistics data
(numerator) and the Current Population Survey (denominator). The CPS is conducted by
the U.S. Census Bureau and collects data on labor force statistics and other topics of
relevance for the non-institutionalized civilian population in the U.S., though it is used
here to create age-specific population estimates disaggregated by race-ethnicity, nativity,
and sex. For this study, the Annual Social and Economic (ASEC) supplement of the CPS
is used. The ASEC supplement is collected each year in the month of March, contains
detailed social and economic characteristics on respondents in the sample, and provides
an oversampling of the Hispanic population in the U.S. ASEC data for years 1997 to
2015 were retrieved from IPUMS and allow for the calculation of population estimates.
The sample from each survey is weighted according to IPUMS instructions to produce a
representative estimate of the U.S. population3.
All-cause mortality counts for years 1997-2015 come from the NCHS Multiple
Cause of Death files (MCD) and were retrieved from the National Bureau of Economic
Research’s website. These data contain information (e.g. demographics of decedents,
causes of death, and other related details) from death certificates of persons that have
died in the U.S. and District of Columbia. The most current national mortality data at the
time of conducting this study was for year 2015. As such, the span of years covered by
this study ends with year 2015.

3

See Appendix 1-1 for explanation of sample weights.
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Measures
Measures of functional limitations from NHIS data will be used as an indicator of
morbidity for this paper and ultimately determine healthy and unhealthy states.
Functional limitations are basic physical actions that are generally used in a multitude of
circumstances throughout daily life and precede disability in the disablement process
(Verbrugge & Jette, 1994). Unlike ADLs, functional limitations are not contingent upon
an individual’s environment and/or equipment that could be used to bypass issues of
disability. In other words, individuals might be similar in regard to functional limitations,
though differing environments or the use of healthcare equipment can result in a
disability for one individual and the absence of such for another. Other studies on
morbidity compression among Hispanics in the United States also use functional
limitations to measure disability (Cantu et al. 2013).
The NHIS survey items used to operationalize functional limitations in this paper
ask adult respondents to indicate how difficult it is for them to complete the following
tasks without assistance from others or the use of special equipment: walk a quarter of a
mile; walk up ten steps without resting; stand for two hours; sit for two hours; stoop,
bend, or kneel; reach overhead; grasp or handle small objects; and lift/carry objects
weighing up to ten pounds. Following Cantu et al. (2013), respondents who indicated that
the task was “very difficult” or that they could not do the task at all (“can’t do at all”) will
have a functional limitation in regard to that particular task. Those that indicated having a
lesser degree of difficulty (“only a little difficult”; “somewhat difficult”) or no difficulty
at all are considered to be in a healthy state4. Once these functional limitation items were

4

See Appendix 1-2 for NHIS Recodes in detail.
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recoded into dichotomous variables, they were combined into a single variable indicating
the number of functional limitations held by a respondent. If the respondent has one or
more functional limitations, s/he is considered functionally limited.
Other variables used in the analysis – all of which are self-reported in the NHIS
and CPS – include age, race, gender, Hispanic ethnicity, and nativity status. The NHIS
asks individuals if they consider themselves to be of Hispanic origin, and also asks them
to indicate the groups representing their Hispanic ancestry (e.g. Puerto Rican, Mexican,
or Mexican American). Considering that this paper is only concerned with Hispanic
origin broadly and not subgroups, a recoded, dichotomous variable that indicates
Hispanic origin is used instead. As mentioned, non-Hispanics blacks, non-Hispanic
whites, and Hispanics are the groups being compared for this research proposal, however
Hispanics will be disaggregated by nativity status. Nativity status is operationalized with
a NHIS item that asks respondents to indicate if they were born in the U.S. or elsewhere.
I combine these variables into the following mutually exclusive categories: non-Hispanic
white, non-Hispanic black, foreign-born Hispanic or U.S. born Hispanic.
As for mortality counts, the MCD data used here contains a recoded Hispanic
origin and race variable that includes Hispanic subgroups, non-Hispanic whites, and nonHispanic blacks; this variable was recoded further to where Hispanic subgroups were
combined to make a singular category indicating Hispanic origin, regardless of subgroup. To disaggregate Hispanics by U.S. nativity status, a variable indicating state of
birth or county of birth (if born outside of the U.S.) was recoded into a dummy variable
to indicate if the decedent was born in the U.S. (one of the 50 states or Washington, D.C.,

14

territories excluded) or elsewhere. Using these variables, I create a single raceethnicity/nativity group variable as described in the preceding paragraph.
As with the other sources of data, the CPS contains variables indicating the race,
ethnicity, and nativity status of respondents. Similar to the NHIS data, Hispanic origin is
indicated by sub-group. I recode this into a dichotomous variable indicating Hispanic
origin, regardless of sub-group, and then create a single race-ethnicity/nativity group
variable as detailed with other data sources used here.
Methods
In order to determine whether compression or expansion has occurred for the
aforementioned race-ethnicity groups, multi-state life tables will be created using the
Sullivan Method.5 The Sullivan method allows for assessment of various life expectancy
health states (i.e. healthy and unhealthy) according to prevalence-based measures (Jagger,
et al., 2014). The Sullivan method partitions TLE at a given age into future years lived in
a healthy vs. unhealthy state. The use of multi-state life tables created with the Sullivan
method also allows for a comparison of life expectancies at various health states across
populations or different points in time. This method is convenient in that it allows for the
use of cross-sectional data which are more readily available than longitudinal data
(Jagger et al., 2014). However, there is a possibility of over or underestimating life
expectancy for a particular health state in instances where prevalence between two
different times remains static (Mathers as cited in Jagger et al., 2014).

5

See Appendix 1-3 for multi-state life table calculations.
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Population estimates, death rates, and prevalence rates must be calculated before
creating multi-state life tables. This is done for 5-year age categories, with the exception
of ages 18-24 (the first age-category) and the closed age category of 80+. When
calculating death rates, CPS population estimates serves as the denominator. These
population estimates are produced by weighting CPS data according to the recommended
sampling weight. Given that the CPS and NHIS collect information on the noninstitutionalized population and the MCD contains data on all deaths (including those of
non-institutionalized and institutionalized persons) in the U.S., numerator-denominator
bias presents a problem; this is especially the case for the elderly persons that may reside
in a long-term care facility. To mitigate this issue, deaths occurring in nursing homes are
removed from analyses, lest artificially high mortality rates be calculated for older
persons in this study. Lastly, NHIS data is weighted using the appropriate sample
weights, and then age and gender-specific prevalence rates – based on the presence of
functional limitations – are calculated for each aforementioned group6.
Once annual population estimates, death counts, and prevalence rates were
produced for each group, an additional step of creating 5-year moving averages was taken
(e.g. years 1997-2001 are averaged and referenced as the center year 1999 in the figures,
tables, and discussion that follow). As such, the centered years 1999-2013 are used in
analyses. This was primarily done to remove empty, unweighted cells that were present
when calculating prevalence rates but also served to smooth CPS population estimates.
After these steps, life tables for black, white, U.S. born (USB) Hispanic, and
foreign-born (FB) Hispanic male and females adults can be created separately for years
6

See Appendix 1.4 for information on CPS and NHIS weights.
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1999 to 2013 (a timespan restriction imposed by implementing 5-year moving averages).
The impetus for making comparisons among these groups is rooted in Hispanic Paradox
literature. Health differences between native-born and foreign-born Hispanics in the U.S.
are evident based on the literature cited above. Comparisons of Hispanics –especially
those born outside of the U.S.– to whites is essential for testing and furthering Hispanic
Paradox literature, as the groups would be expected to have similar outcomes in regard to
all-cause mortality. A minor comparison of Hispanics to blacks in this paper is warranted
because of similarities in SES between the groups; evidence has suggested that health
outcomes are influenced by SES (Sorlie et al., 1995). Comparisons across gender are
made to see how health trends differ for males and females; doing so will also make this
research more comparable to numerous studies that have also considered differences in
health by gender (Cantu et al., 2013; Crimmins et al., 1996; Crimmins & Saito, 2001;
Hayward & Heron, 1999; Lariscy et al., 2015).
In creating multistate life tables that exhibit changes in healthy life expectancy (or
DFLE specifically here), the changes in the expected number of years lived with and
without functional limitations can be observed for each subpopulation group.
Accordingly, eight life tables will be created for each year from 1999-2013: one each for
non-Hispanic white females, non-Hispanic black females, foreign-born Hispanic females,
U.S. born Hispanic females, and then the same for males of each group. Ultimately,
changes in the percentage of TLE that is spent disability-free (abbreviated to DFT) over
the years will be compared within and between groups. This will reveal any morbidity
changes that have occurred, and comparisons will be made between the groups to
determine who has fared better in these changes. Additionally, locally weighted
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regression (loess) lines were predicted for DFT trends of each group; these lines are seen
in figures where DFT is plotted.7 The purpose of this procedure is to produce a smooth
line that make trends more discernable through the noise observed in the data.8 With this
visual aid, comparisons of DFT trends over time for different groups are also less
complicated.

7

See Appendix 1-4 for explanation of loess lines.
Significance tests for analyses here use values from multi-state life table calculations, not the predicted
values of individual loess lines. The loess line exists exclusively for visual representation of trends across
the time-series plots in analyses here.
8
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CHAPTER IV
RESULTS
Figures here display trends of TLE, DFLE, and DFT that are stratified by raceethnicity, nativity status (for Hispanics only), gender, and age group (65-69, 80+)
between 1999 and 20139. Figures showing TLE and DFLE denote compression if DFLE
increases as TLE remains static or decreases. Expansion occurs if TLE increases while
DFLE remains static or decreases. If TLE and DFLE both increase or decrease
simultaneously, compression or expansion cannot easily be discerned. While the relation
of TLE and DFLE trends may indicate compression or expansion, changes in DFT can
elucidate the occurrence of compression or expansion more clearly. Figures showing
DFT trends will denote compression as DFT increases (incline), whereas expansion is
denoted when DFT decreases (decline). These figures also feature confidence intervals
indicating if between-group differences in DFT are significant or not. Standard error and
z scores were calculated to test for significant, within-group changes in DFT.
Non-Hispanic Whites
Figure 1 shows trends in TLE and DFLE among white men and women at ages
65-69 and 80+. TLE has increased overall from 1999-2013 for white males and females

9

While figures are central to the discussion of findings here, Table A1 (ages 65-69) and Table A2 (ages
80+) show the values of TLE, DFLE, and DFT and can be found in the Appendix. Tables showing values
of TLE, DFLE, and DFT based on unweighted prevalence rates from the NHIS can be found in the
Appendix as well. Abridged life tables for ages 18-80+ are available upon request.
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aged 65-69 and 80+, though white females at both ages experience a minor loss in TLE
during last few years observed. DFLE of white males remains static in some years but has
increased from 1999-2013 for the 65-69 age group and from 2008-2013 for the 80+ age
group. DFLE trends for white females at both ages are similar to their TLE trends in that
they increased from 1999 to 2008, though DFLE declined for the remaining years
observed. Overall, the years gained in DFLE for whites are dwarfed by the gains in TLE,
regardless of gender and age group. Given that white males experience some periods of
static change in DFLE while TLE increases between 1999-2008, expansion is evidenced
in that time span.
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Figure 1

Total life expectancy and disability-free life expectancy for whites by gender
and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
Indeed, Figure 2 suggests that white males at ages 65-69 and 80+ have
experienced morbidity expansion from the late 1990s to the late 2000s. The decline in
DFT suggests that this expansion was significant at ages 65-69 (p < .05, z = 4.69) and
80+ (p < .05, z = 3.21). For white females at ages 65-69, expansion seems to have
occurred from 2001-2013, and this change is significant, based on the decline in DFT (p
< .05, z = 3.81). However, a significant period of morbidity compression occurred from
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1999-2004 among white females at ages 80+ (p < .05, z = 3.19), and a significant period
of expansion was experienced afterwards from 2004-2013 (p < .05, z = 3.53). Finally, at
ages 65-69 and 80+, DFT decreased more sharply for males than females over the period
examined.

Figure 2

Percentage of total life expectancy lived disability-free for whites by gender
and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
Non-Hispanic Blacks
Figure 3 shows an upward trend in TLE for black males and females at age 65-69
and 80+ over the observed period, but trends in DFLE were more varied. Overall, DFLE
increased among black males aged 65-59 and 80+ from 1999-2013, though DFLE for the
latter age group dipped from 2004-2007. DFLE increased overall from 1999-2013 for
black females at ages 65-69 and 80+, though black females at ages 65-69 experienced a
minor decline of .2 years in DFLE from 2010 to 2013. Regardless of age group and
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gender, blacks saw greater increases in TLE than DFLE, but increases in DFLE were
more substantial than those of whites. The patterns of change in TLE and DFLE suggest
that expansion occurred for black males from 2004-2008, though a period of compression
seems to have occurred earlier on among black males ages 80+, while a period of
expansion seems to have occurred from 2002-2008 for black females ages 80+.

Figure 3

Total life expectancy and disability-free life expectancy for blacks by gender
and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
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Figure 4 shows that black males at ages 65-69 and 80+ indeed experienced
morbidity compression from 1999 to 2003, though this was only significant for those in
the 80+ age group (p < .05 z = 2.09). Black males do see subsequent expansion from
2004-2008 and compression from 2008-2013 after this period, but these changes are not
significant (p > .05). Black male and females both have similar trends at ages 80+, but
changes in DFT were less pronounced for black females and also not significant (p >
.05). For example, black males at age 80+ saw an increase of 13.6 points in DFT from
1999-2003, whereas black females in the same age-group only saw an increase of 7.5
points. As for black females at ages 65-69, DFT simply fluctuates between a low of 48.3
points and a high of 51.6 points from 1999-2013.

Figure 4

Percentage of total-life expectancy lived disability-free for blacks by gender
and age.

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
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U.S. Born Hispanics
Figure 5 shows that trends in TLE and DFLE are more varied for USB Hispanics
than whites and blacks. TLE is higher in 2013 than it was in 1999 for USB Hispanics
males and females at both age groups, though it fluctuates noticeably across time. The
same is true for DFLE, though these gains in DFLE are smaller than those seen for TLE,
especially for the oldest USB Hispanic males and females. A notable shift in seen in
DFLE for both USB males and females at 2008, though this varies by gender. The
upward trend in DFLE for USB Hispanic males become level, albeit with some
fluctuation. On the other hand, USB Hispanic females begin to see a relatively steady
decline in DFLE throughout 2013. These trends in TLE and DFLE imply that morbidity
expansion occurred for USB Hispanic women from around 2009-2013 and 2001-2006 for
USB Hispanic males.
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Figure 5

Total life expectancy and disability-free life expectancy for U.S. born
Hispanics by gender and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
Figure 6 shows that expansion actually occurred for USB Hispanic males from
1999-2006, and this period is followed by brief compression from 2006-2008 before
leveling out with some fluctuation. The decreases in DFT that denote expansion for USB
Hispanic males at ages 65-69 (8.1. points) and 80+ (16.9 points) are sharp, but these
changes in DFT and others for these males are not significant (p > .05). For females in
both age groups, a short period of compression is seen from 2005-2008, but this is
26

followed by expansion from 2008-2013 due to the noted decline in DFLE during the
same time. However, these periods of change for USB Hispanic females are also not
statistically significant (p > .05).

Figure 6

Percentage of total-life expectancy lived disability-free for U.S. born
Hispanics by gender and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
In regard to between-group differences for USB Hispanic males and females,
overlapping confidence bars are present in every year for males and females at ages 80+,
therefore no significance difference exists for USB Hispanics by gender at this age (p >
.05). Additionally, convergence is seen for males and females at age 80+ from 20042008. USB Hispanics males and females at ages 65-69 have significantly different DFT
for years 1999-2003 and 2010-2013 (p < .05), though DFT for years 2004-2009 is not
significantly different by gender (p > .05). Additionally, the pattern of change in DFT for
USB Hispanics male and females at ages 65-69 is similar from 2004-2009.
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Foreign-born Hispanics
Figure 7 shows that TLE increased between 1999-2013 for foreign-born (FB)
Hispanic males and females at ages 65-69 and 80+, though there are some periods of
decline and stagnation in TLE during these years. Only FB Hispanic females experienced
a net increase in DFLE from 1999-2013, though DFLE follows a downward trend from
2007-2012. DFLE for FB Hispanic males does not slowly trend downward, but rather
fluctuates from 1999-2013. Increases in TLE and mostly static DFLE for FB Hispanic
males suggest that expansion might be seen throughout 1999-2010, but the fluctuation in
DFLE should affect the direction of DFT at some points. The increase in DFLE and the
accompanying decline in TLE suggest that FB Hispanic females experienced morbidity
compression between 1999 and 2002. However, this group also seems to have
experienced morbidity expansion between 2007 and 2011 given the decline in DFLE and
increase in TLE that occurred during this period.
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Figure 7

Total life expectancy and disability-free life expectancy for foreign-born
Hispanics by gender and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
Figure 8 shows that morbidity expansion has occurred for both FB Hispanic males
and females at ages 65-69 from 1999-2010 and 2006-2011, respectively. This change is
significant based on the decline in DFT for males (p < .05, z = 2.28) and females (p < .05,
z =2.53) in this age group during that period. For FB Hispanic females at age 80+, a
compression is actually evident from 1999-2006 based on DFT, but then expansion
occurred from 2007-2011. FB males in the same age group experienced a downward
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trend in DFT from 1999-2010, but notable fluctuation occurs during this time. Despite
the sizable changes in DFT for the oldest FB Hispanic males and females, these trends
did not exhibit any significant change.

Figure 8

Percentage of total-life expectancy lived disability-free for foreign-born
Hispanics by gender and age

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
In regard to between group differences, the gap in DFT for FB Hispanic males
and females aged 80+ is not significant from 2000-2013 (p > .05). As such, it cannot be
said that the two genders are different in regard to DFT with the exception of that year.
However, actual values of DFT do appear to be similar at many points throughout the
observed period. Additionally, the pattern of change is, of course, different for FB
Hispanic males and females at ages 80+ from 1999-2007. For FB Hispanic ages 65-69,
DFT is significantly different for males and females during years 1999-2005 and 20112013 (p < .05), though the two groups are not significantly different from 2006-2010 (p >
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.05). Additionally, males and females at ages 65-69 trended downward similarly from
2007-2010.
Hispanics by Nativity
Figure 9 shows DFT trend comparisons by nativity. As noted earlier, FB
Hispanics males and females at ages 65-69 experienced significant periods of expansion
while their USB counterparts did not. However, periods of similar trends are still seen.
From 2008-2012, USB and FB Hispanics male and females at ages 65-69 had similar
trends, with the males’ DFT leveling out -albeit with some fluctuation- and females’
experiencing expansion and leveling out. Additionally, FB Hispanic males at ages 65-69
saw similar expansion from 1999-2002. Hispanic males in the 80+ age group also appear
to be leveling out similar to those in the 65-69 age group but with more fluctuation.
Hispanics females in the 80+ age group saw expansion from 2008-2011. Despite these
trends, DFT confidence intervals overlap in every year for USB and FB Hispanics, thus
DFT for FB and USB Hispanics -compared by their respective age group and gender- is
not significantly different at any year (p > .05).
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Figure 9

Percentage of total-life expectancy lived disability-free for Hispanics by
nativity, age, and gender.

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
Hispanic and Non-Hispanic White Comparisons
Figure 10 shows that whites had trends that were more stable than USB
Hispanics. While whites generally have higher DFT values than USB Hispanics
regardless of gender or age group, overlapping confidence intervals must be considered.
DFT confidence intervals overlap initially for males compared here, but DFT is
significantly different for the 65-69 age group from 2002-2006 (p > .05) and those in the
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80+ age group from 2003-2006 (p > .05). This is due to the fact that the expansion
experienced here is much steeper for USB Hispanic males. These significant differences
between whites and USB Hispanic males disappear, as the latter group saw brief
compression from 2006-2008. DFT for white females and USB Hispanic females at ages
65-69 is significantly different from 1999-2005 and 2012-2013 (p > .05). In other words,
USB Hispanic females at ages 65-69 see compression from 2005-2008 while their white
counterparts are slowly experiencing expansion. USB Hispanic females then see a
sharper decline relative to white females from 2008-2013. Additionally, females at ages
80+ here do not have significant between group differences in DFT from 1999-2013 (p >
.05), but the general pattern of change is similar to those of the 65-69 age group. The
upward trend in DFT for U.S. born Hispanics males and females suggests a period where
each may have fared better -at least in morbidity change- than their white counterparts in
the same age and gender group, but USB Hispanics are otherwise worse off than whites.
Additionally, only significant changes were seen for whites in this comparison.
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Figure 10

Percentage of total-life expectancy lived disability-free for whites and U.S.
born Hispanics by age and gender

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
In comparing morbidity trends for whites and FB Hispanics, Figure 11 shows
very similar trends for males and females in both age groups, though some exceptions do
appear. First, FB Hispanics at ages 80+ differ from whites somewhat. They experience
somewhat sharper decline than white males in the same age group from 1999-2002.
Additionally, some notable fluctuation exists for these older FB Hispanic males from
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2003-2008 while white males in the same age group are beginning to level out from a
slow decline. Second, FB Hispanic females at ages 80+ are actually experiencing steeper
compression than white females in the same age group from 1999-2004. Third, FB
Hispanics males and females saw a period of expansion from 2007-2011 that was not
matched by white males and females. DFT subtly trended upwards for white males and
subtly trended downwards for white females during this period. However, DFT for FB
Hispanic males levels out after this period and curves upwards for FB Hispanic women,
putting FB Hispanics back into a pattern of change similar to whites. Aside from females
at ages 80+, it was in this exceptional period from 2007-2011 that the between-group
differences in DFT became significant for FB Hispanics and whites (p > .05).
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Figure 11

Percentage of total-life expectancy lived disability-free for whites and
Foreign-born Hispanics by age and gender

SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file,
National Health Interview Survey
NOTES: 95% confidence intervals in parentheses. Dashed line represents loess line.
Aside from similarities seen between FB Hispanics and whites in regard to DFT
trends, it is important to note a few other differences. First, only significant changes in
DFT existed for white males and females in the 80+ age group, due to the large standard
error that existed for FB Hispanics in the same age group. Second, the changes in TLE
and DFLE that affect DFT vary by group. For FB Hispanic males in the 65-69 age group,
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expansion is occurring because TLE is increasing while DFLE does not increase.
Additionally, the compression that FB Hispanic females saw is the result of TLE
decreasing while DFLE increases. Meanwhile white male and females at the
corresponding ages are both saw increases in TLE and DFLE, but the rates of change
between the two measures result in expansion for white males aged 65-69 and
compression for white females aged 80+. In other words, while FB Hispanics and whites
may look similar in terms of compression or expansion based DFT trends, some age and
gender groups differ in TLE and DFLE trends.
While comparison figures not are shown, a brief comparison of blacks to USB
and FB Hispanics is merited. Surprisingly, blacks fared better than Hispanics regardless
of nativity in regard to DFT trends. Disregarding black females at ages 65-69, other
blacks do experience expansion, but this occurs after substantive compression.
Additionally, another period of compression occurs after the expansion, for an overall
increase in DFT from 1999-2013 for blacks.
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CHAPTER V
DISCUSSION AND CONCLUSION
From 1999-2013, this study finds that the occurrence of morbidity compression
and expansion varied by race-ethnicity, gender, and nativity for Hispanics. Additionally,
continuous expansion and compression across the entirety of the timespan were
uncommon. Many groups experienced periods of expansion and compression at different
points; this was most notable among USB Hispanics, blacks, and the oldest white and FB
Hispanic women. FB Hispanic males at ages 65-69 were unique in that they experienced
nearly continuous expansion throughout the timespan. Despite the fact that most groups
experienced both compression and expansion at some point in time, most groups had
lower DFT in by 2013 than they did in 1999. This was the most severe for FB Hispanics
males, though white males and females, USB Hispanics male, and FB Hispanics females
in the 65-69 age group also had lower DFT by 2013. On the other hand, black males and
females and the oldest FB Hispanic females had higher DFT in 2013 than in 1999. As
such, blacks here generally had the most favorable trends in DFT from 1999-2013 of all
race-ethnicity-nativity groups. With the exception of black females at ages 65-69, blacks
have also been experienced steady compression in the most recent years observed here.
The comparison of DFT for males and females show some similarities and
differences in trends by race-ethnicity-nativity group. Whites and USB Hispanics tended
to have different DFT trends overall, based on the timing of occurrence for compression
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and expansion of morbidity. Additionally, the latest trends in DFT show that white and
USB Hispanic males have recently fared better than their female counterparts. White
males have recently experienced compression, and USB Hispanic males have DFT that
was relatively level, albeit with fluctuation. White and USB Hispanic females have most
recently experienced expansion however. Black and FB Hispanic males and females have
more similar trends though. Black males and females at ages 80+ had noticeably trends in
DFT, though the trend varies by gender for the 65-69 age group. FB Hispanic males and
females experienced relatively similar DFT trends from 2002-2013, though fluctuation
does exist for the groups. Excluding black females at ages 65-69, black males and
females experienced compression in the most recent years, and DFT for FB Hispanic
males and females has leveled out and suggested a slight upward trend.
The main focus of this study was to compare recent trends in DFT between
Hispanics and non-Hispanic whites. Given that that my primary goal was to examine
whether the Hispanic Paradox extends to changes in DFT over time, it is perhaps best to
begin by understanding that nativity status is a large part of the Hispanic advantage. To
clarify, if the Hispanic paradox extends to recent trends in DFT, foreign-born Hispanics
should fare similar or better than whites, while U.S. Hispanics should fare worse than
their foreign-born counterparts and potentially worse than whites. A comparison of
morbidity trends by nativity yields some evidence of similarity between USB and FB
Hispanics, but the comparison of these groups to whites highlights the differences
between USB and FB Hispanics also. FB Hispanic seem to be mostly similar to whites in
regard to morbidity trends, though some periods show discrepant trends (most notably FB
Hispanics experiencing a sharper decline in DFT for a short span of time). Also,
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significant changes in DFT did not occur for the oldest FB Hispanics, while whites in the
same age group did see significant changes.
USB Hispanics, on the other hand, seemed to have fared somewhat worse than
whites overall given the periods of expansion that were much sharper for USB Hispanics
than whites. There were points where USB Hispanics seems to fare similarly (i.e.
experiencing DFT decline at a similar rate during a period of time) and even better than
whites (i.e. experiencing an upward trend in DFT while whites experienced a downward
trend). However, it is important to acknowledge that confidence intervals are larger for
both Hispanic groups relative to whites as a results of meager sample sizes for the former.
Additionally, the changes in DFLE and TLE that affect DFT add depth to the discussion
and show evidence that might run counter to the Hispanic Paradox, at least for some
gender and age groups. Regardless of gender, whites were more likely to experience
expansion as a result of TLE simply increasing at a faster pace than DFLE did, whereas
FB Hispanic males seen to be experiencing growth in TLE but have somewhat level –
albeit fluctuating– DFLE. On the other hand, FB Hispanic females saw growth in TLE
and DFLE like whites, at least until 2008.
In light of these findings, partial support is found for the Hispanic Paradox’s
extension to morbidity trends (that is morbidity compression and expansion). However,
the story that is told by changes in DFLE for whites relative to FB Hispanics suggests
that there is more to this discussion. USB Hispanics overall fared worse than whites, but
the period of compression that the former experienced was notable. FB Hispanics tended
to fare similar to whites, but the steep decline that these FB Hispanics experienced from
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2008-2011 was also notable. Additionally, the large standard error for Hispanics’ DFT
must be factored in.
There is potential that more solid evidence for the Hispanic paradox (i.e. no
deviation in trends for whites and FB Hispanics) would have been found if higher quality
population data was used in this study, but this cannot be said with certainty. There is
also another potential explanation however. The different degree of expansion between
FB Hispanics and whites occurred roughly around 2008-2011. Additionally, 2008-2009 is
the period where compression for USB Hispanics stopped as DFT began to level out for
USB males and began to decline for USB females. The decline in DFT for FB Hispanics
males/females and USB Hispanic females during this time is largely a result of DFLE.
USB Hispanics experience TLE and DFLE decline during this time that makes DFT level
out, albeit with fluctuation. Given the coinciding time period, the economic downturn
that the U.S. experienced during this time (i.e. the Great Recession) comes to mind.
Though this study makes no aim to explore this potential connection, future research
might consider the effects that the recession had on the prevalence of functional
limitations of Hispanics and other groups during this time. This might be particularly
important for USB Hispanics. The negative change to DFT during this time did not cease
eventually for USB Hispanics as it did for FB Hispanics, whose DFT eventually leveled
out from decline and suggested incline in the final years observed.
Additionally, future research should use higher quality data and observe trends in
TLE, DFLE, and DFT for the groups studied here. Comparisons of morbidity trends for
FB Hispanics, USB Hispanics, and whites where other measures of morbidity (e.g.
activities of daily living, chronic morbidity) should also be considered. Given the meager
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sample sizes for minority groups here, future studies might also observe the morbidity
trends of larger, and potentially younger, age groups. Lastly, future research should make
attempts to disaggregate these groups by educational attainment in order to produce
results that are more comparable to past research that has considered compression and
expression of morbidity by race and education (Crimmins et al., 1996; Crimmins & Saito,
2001; Sole-Auro et al., 2012). Future research that considers these suggestions might
build upon this present study to gain a better understanding of racial-ethnic disparities in
the amount of total life lived in an unhealthy state, how this is influenced by SES, and
how these disparities have changed gradually over time. While past literature has tended
to assess morbidity changes across perhaps two or three points in time, the ability to
observe patterns of change in a time series with many point as they exist in this study
(and ideally future studies) are beneficial in understanding the degree of change in
morbidity and its timing across different groups. Through the lens the Hispanic paradox,
future studies incorporating these suggestions would also be revealing in not only how
other morbidity trends might extend to the paradox but perhaps how the extent of the
paradox has changed over time as well.
This research is not without limitations. First, the dynamic equilibrium hypothesis
is not considered here, as changes in severity of functional limitations are not examined.
Another limitation is that this study makes use of ASEC population estimates from the
month of March. While intercensal estimates would be of higher quality than the ASEC
estimates, such data does not readily allow for the disaggregation of Hispanics by nativity
status. Also, ASEC estimates from March are used instead of midyear CPS estimates
given that Hispanics are oversampled in the ASEC supplement. Midyear estimates are, of
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course, typically used for the calculation of life tables. Third, there is likely some degree
of racial-ethnic misclassification that exists in mortality data here. Next, foreign-born
Hispanics are not further differentiated by nationality to assess health differences that go
beyond their foreign-born status. A fifth limitation is the presence of numeratordenominator bias, though the exclusion of deaths occurring in nursing homes mitigates
this problem greatly. This bias is present when data for the deceased and for those at-risk
come from two different sources. In this paper, the at-risk population in the CPS data (the
denominator) is not the same population including the decedents of the NCHS vital
statistics (the numerator). Lastly, a limitation exists in that groups studied here are only
disaggregated by sex, race-ethnicity, and nativity (for Hispanic men and women). While
controlling for other variables (e.g. education) would be ideal and add a wealth of
additional detail to this study, it is not feasible given the already meager sample sizes of
minority groups contained in the present data.
Despite these limitations, this research found that most groups examined here
experienced periods of morbidity compression and expansion from 1999-2013. Perhaps a
more central finding though was evidence providing partial support for the extension of
the Hispanic paradox to trends in the percentage of total life expectancy that is lived
disability-free, as these trends were similar for white and FB Hispanic males and females.
While this study adds to the the body of Hispanic paradox literature, future research
should attempt to replicate findings here, make use of higher quality data for life
expectancy calculations, and extend these findings.
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A.1 Sampling weights
Sampling weights were applied to both CPS and NHIS datasets used here. Both
the CPS and NHIS use complex, multi-stage stratified sampling designs and oversample
certain groups. The years of the CPS used here include an oversampling of Hispanics,
whereas the years of the NHIS used here contain an oversampling of Hispanics and
blacks. To correct for oversampling and other factors, sampling weights prescribed for
use by the Census Bureau and National Center for Health Statistics have been used. With
the CPS, the supplement weight (WTSUPP) is to be used with ASEC data. It is based on
the inverse probability of being included in the population sample, corrects for
oversampling, the known age, sex, and racial distribution of the entire population, failure
to interview a respondent, sampling within large sample unit and also gives husbands and
wives an identical weight. In the NHIS data, the sample person weight (SAMPWEIGHT)
to be used with the adult sample file is based on the inverse probability of being included
in the sample that completes an adult/child supplement, corrects for non-response and
oversampling, and applies adjustments based on the Census Bureau’s population control
totals.
A.2 Functional limitation recodes
While the recoding process for the functional limitation items in the NHIS are
discussed in the body of this research, additional detail is given here. The functional
limitation items asked respondents “how difficult it is to…
a. “carry 10lbs without special equipment?”
b. “walk up 10 steps without special equipment?”
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c. “grasp objects without special equipment?”
d. “reach overhead without special equipment?”
e. “sit 2 hours without special equipment”?
f. “stand 2 hours without special equipment”?
g. “stoop/bend/kneel without special equipment?”
h. “walk one-quarter mile without special equipment?”
(An additional functional limitation item which asks “how difficult it is to push large
objects without special equipment?” exists in the NHIS, but this item is not considered in
analyses here as the author feels that such a task might be difficult for many individuals
who would otherwise not have any physical limitations). Respondents were allowed to
give the following responses to the above items:
a. Not at all difficult
b. Some difficultly
c. Only a little difficult
d. Somewhat difficult
e. Very difficult/a lot
f. Can’t do at all/completely unable
g. Do not do this activity
Here the items are dichotomized where “very difficult/ a lot” or “can’t do at
all/completely unable” constitute the presence of a functional limitation. Answering with
a lower level of difficultly than “very difficult” indicates that the respondent is not
functionally limited based on that item. “Not doing” one of these activities is not
necessarily indicative of having difficultly nor does it mean that the task can be
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completed without any difficulty. Accordingly, these responses are not included when
considering the presence of functional limitations for a respondent. Following the
dichotomization of these variables, they were combined into a scale where the presence
of at least one of these functional limitations (i.e. a score of 1 of higher) indicates that the
respondent is functionally-limited.

A.3 Multi-state life table calculations
Multistate lifetables for persons age 18 and older in this research were created
using the Sullivan method as explained by Jagger et al. (2014). Such a method allows for
the use of cross-sectional prevalence measures partition life expectancy into two states:
healthy and unhealthy. Additionally, Jaggar et al. (2014) explain the calculation of
variance, confidence intervals for DFLE and DFT, and z tests to check for significant
difference between DFLE and DFT. These calculations are listed and explained in detail
here. Age-specific death rates are calculated as:

(A.1)

where nDx is the number of deaths at age 𝑥 occurring in the period of length 𝑇, and nPx is
the average size of the population exposed to the risk of death. (𝑇 is treated as one year in
life tables used in this research, though the actual size of the population is actually an
average of the U.S. population over 5-year increment). The proportion of those alive at
age x is calculated as:
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(A.2)

where ax is the fraction of the last year that a person lived. ax here is set to 0.5, under the
assumption that deaths have a uniform distribution in the age intervals. 𝓁x is the number
of persons surviving to age 𝑥 and is set to 100,000 for the first age in the life table to
represent a hypothetical cohort of 100,000 persons. At subsequent ages, 𝓁x is calculated
as:
.

(A.3)

The total number of years lived by a cohort in an age interval (𝑛𝐿𝑥) is calculated as:

.

.

(A.4)

With the exception of the final age interval, each person surviving an age interval will
contribute a number of years that is equal to the size of that interval. For the final age
interval, the total number of years lived at said interval is calculated as:

.

(A.5)

where 𝜔 represents the final age interval. Life expectancy can now be calculated for age
𝑥 as:
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.

(A.6)

The calculation of disability-free life expectancy for age 𝑥 is calculated as:

(A.7)

where 𝜋𝑖 represents disability prevalence at age i. The variance of DFLE can be
calculated as:

(A.8)

where 𝜋𝑖 is the weighted prevalence of disability and Nx is the unweighted sample of
persons -specific to their age, gender, race-ethnicity, and nativity- that were surveyed in
the NHIS and asked about functional limitations. From here, a test for significance
difference between two different DFLEs can be calculated as:
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.

.

(A.9)

This same equation can also be used to a test for significance difference for DFT (noted
below as DFLEx/ex) where the variance of DFT is calculated as:
.

.

(A.10)

Lastly, 95% confidence intervals can be calculated for DFLE as:

.

.

This same equation can be used to create confidence intervals for DFT.
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(A.11)

A.4 Loess lines
Locally weighted regression is a method of fitting a regression surface to a set of
data via multivariate smoothing (Cleveland & Devlin, 1988); the use of local fitting to
smooth data also has roots in time-series analysis (Macaulay, 1931). Loess is a nonparametric method of regression, as it does not assume linearity. It is local in the sense
that the line being fit is based on data in the vicinity of x, rather than data globally
(DFLE/TLE values in this case) across the time plot. While locally weighted regression
has other uses, it also serves as a tool to observe the behavior of data (Cleveland &
Devlin, 1988). Accordingly, it is used here simply to provide a graphical aid to the time
series data in this thesis (i.e. changes in DFT over time). R, a software environment for
statistical computing, was used to apply loess lines to figures showing DFT trends in this
thesis. Parameters in the function loess include α (i.e. the proportion of values in the
vicinity of x that affect the fit) and degree (i.e. the degree of polynomials being used). α
essentially affects the level of smoothing and is set to .55. A degree of 2 (i.e. quadratic) is
also used. These parameters were chosen based on how well these they allow a line to fit
the noisier data in analyses above. Based on the author’s visual inspection, these
parameters provide the best fit without either over-smoothing the data or fitting too
closely to the data in a way that defeated the purpose of smoothing the data.
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TLE

18.2

18.3

18.6

19

19.4

19.7

20

20.1

20.2

20.3

20.5

20.7

21

21

21

Year

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

Table 1

14.1

14.2

14

13.9

13.6

13.4

13.4

13.4

13.3

13.2

13.3

13.2

13.1

13

12.9

DFLE

67.2 (66.3 - 68.2)

67.4 (66.5 - 68.4)

66.7 (65.7 - 67.7)

66.9 (65.9 - 68)

66.3 (65.2 - 67.5)

66.1 (64.9 - 67.2)

66.3 (65.2 - 67.4)

66.6 (65.5 - 67.7)

66.4 (65.4 - 67.5)

67.3 (66.2 - 68.3)

68.6 (67.7 - 69.6)

69.7 (68.7 - 70.7)

70.6 (69.6 - 71.5)

71.2 (70.2 - 72.1)

70.8 (69.9 - 71.8)

DFT (C.I. - / +)

White Males, ages 65-69

19.1

19.1

18.9

18.2

17.9

17.6

17.2

17

16.9

16.6

16.3

16.2

16

15.9

15.8

TLE

12.4

12.1

11.8

11.5

11.3

11.0

11.0

11.0

11.0

11.1

10.8

10.6

10.5

10.3

9.7

DFLE

65.1 (62.7 - 67.6)

63.5 (61 - 66.1)

62.5 (59.9 - 65)

63.3 (60.7 - 65.9)

63.1 (60.3 - 65.8)

62.7 (59.9 - 65.5)

64.1 (61.3 - 66.9)

64.8 (61.9 - 67.6)

65.5 (62.6 - 68.3)

66.9 (64.1 - 69.7)

66.5 (63.7 - 69.3)

65.5 (62.7 - 68.4)

65.8 (63 - 68.6)

65 (62.2 - 67.8)

61.7 (58.9 - 64.4)

DFT (C.I. - / +)

Black Males, ages 65-69

24.1

24.4

24.3

23.9

24.5

24.9

24.3

22.7

22.2

21.4

20.9

20.7

21.1

21.1

20.9

TLE

15.1

14.7

16.0

15.1

15.3

15.7

14.8

13.0

13.0

12.3

12.2

12.6

13.5

13.6

13.6

DFLE

62.4 (57.4 - 67.4)

60.5 (55.4 - 65.5)

65.7 (60.8 - 70.7)

63.1 (57.7 - 68.5)

62.5 (56.8 - 68.3)

63 (56.8 - 69.2)

61 (54.9 - 67)

57.1 (51.2 - 63.1)

58.3 (52.6 - 63.9)

57.6 (51.9 - 63.2)

58.4 (53 - 63.8)

61 (55.5 - 66.4)

64 (58.5 - 69.5)

64.8 (59.2 - 70.3)

65.2 (59.6 - 70.8)

DFT (C.I. - / +)

USB Hisp Males, ages 65-69

24.9

24.8

24.9

24.9

24.7

24

23.9

23.8

23.7

23.2

22.8

22.6

22.4

22.3

22.4

TLE

14.9

14.7

15.0

14.5

14.7

15.1

15.5

14.8

15.4

15.5

14.8

14.7

15.0

15.2

15.3

DFLE

59.8 (55.9 - 63.6)

59.5 (55.4 - 63.5)

60.5 (56.3 - 64.7)

58.2 (53.9 - 62.5)

59.7 (55.3 - 64.2)

62.7 (57.9 - 67.4)

64.8 (60.1 - 69.6)

62.2 (57.3 - 67.1)

64.9 (60.2 - 69.7)

67 (62.3 - 71.7)

65 (60.6 - 69.4)

64.9 (60.3 - 69.4)

67.1 (62.5 - 71.6)

68.1 (63.3 - 72.8)

68.5 (63.9 - 73)

DFT (C.I. - / +)

FB Hisp Males, ages 65-69

Total life expectancy, disability-free life expectancy, and percentage of life lived without disability by gender,
race-ethnicity, and nativity at ages 65-69, 1999-2013.
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25.1

25.1

25

24.9

2010

2011

2012

2013

13.7

13.8

13.9

14.0

14.0

14.1

14.0

13.9

13.9

13.8

13.6

13.5

13.4

13.2

13.0

DFLE

55.1 (54.3 - 55.8)

55.3 (54.5 - 56.1)

55.5 (54.6 - 56.3)

55.7 (54.8 - 56.6)

55.7 (54.8 - 56.7)

56.3 (55.3 - 57.3)

56.4 (55.4 - 57.3)

56.5 (55.5 - 57.4)

56.8 (55.9 - 57.6)

57.4 (56.5 - 58.2)

57.4 (56.6 - 58.2)

57.9 (57.1 - 58.7)

58.2 (57.3 - 59)

57.7 (56.9 - 58.5)

56.9 (56.1 - 57.7)

DFT (C.I. - / +)

22.7

22.8

22.6

22.4

22.2

21.9

21.6

21.3

21

20.6

20.1

19.7

19.4

19.1

19.1

TLE

11.4

11.5

11.5

11.6

11.4

11.0

10.7

10.5

10.1

10.0

10.1

10.1

9.8

9.5

9.4

DFLE

50.4 (48.5 - 52.3)

50.5 (48.6 - 52.4)

51 (49.1 - 53)

51.6 (49.6 - 53.6)

51.6 (49.5 - 53.7)

50.3 (48.2 - 52.5)

49.7 (47.5 - 51.9)

49.3 (47.1 - 51.6)

48.3 (46 - 50.5)

48.5 (46.2 - 50.7)

50 (47.8 - 52.2)

51 (48.8 - 53.1)

50.3 (48.2 - 52.5)

49.8 (47.7 - 51.9)

49.4 (47.3 - 51.4)

DFT (C.I. - / +)

Black Females, ages 65-69

27.5

27.5

27.6

27.4

27.2

27.9

28

27.8

27.7

27.7

27

26.2

25.3

24.7

24.1

TLE

13.4

13.7

14.0

14.3

14.4

15.7

15.1

14.3

13.7

13.9

13.0

13.2

13.0

12.8

11.8

DFLE

48.6 (44.8 - 52.5)

49.9 (45.8 - 53.9)

50.7 (46.5 - 55)

52.2 (47.7 - 56.8)

53.1 (48.3 - 57.9)

56.3 (51.1 - 61.5)

53.9 (48.9 - 58.9)

51.6 (46.7 - 56.5)

49.4 (44.6 - 54.1)

50.2 (45.5 - 55)

48.1 (43.6 - 52.6)

50.5 (46 - 55.1)

51.4 (47 - 55.8)

52 (47.6 - 56.3)

48.9 (44.6 - 53.2)

DFT (C.I. - / +)

USB Hisp Females, ages 65-69

30

29.5

29.7

29.8

29.2

28.6

28.4

27.4

26.8

26.1

25.5

25.1

25.2

25.4

25.6

TLE

15.0

14.2

14.3

15.4

15.3

15.3

16.1

15.7

14.6

14.6

14.3

14.1

14.1

14.1

13.8

DFLE

49.9 (46.7 - 53.1)

48.3 (45 - 51.6)

48 (44.6 - 51.3)

51.7 (48.1 - 55.2)

52.5 (48.8 - 56.2)

53.5 (49.5 - 57.4)

56.7 (52.8 - 60.7)

57.4 (53.4 - 61.3)

54.3 (50.5 - 58.2)

56 (52.2 - 59.7)

56.2 (52.6 - 59.7)

56.1 (52.5 - 59.7)

56 (52.3 - 59.6)

55.6 (52 - 59.3)

53.8 (50.1 - 57.5)

DFT (C.I. - / +)

FB Hisp Females, ages 65-69

NOTES: 95% confidence intervals in parentheses. TLE: total life expectancy. DFLE: disability-free life expectancy.
DFT: DFLE divided by TLE.
SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file, National Health Interview Survey

25.1

24.4

2005

2009

24.1

2004

25

23.7

2003

2008

23.4

2002

24.9

23

2001

2007

22.9

2000

24.7

22.8

1999

2006

TLE

Year

White Females, ages 65-69

Table 1 (Continued)

60

11.5

11.8

12

12.2

12.3

12.2

2008

2009

2010

2011

2012

2013

11.3

2004

11.5

11.2

2003

2007

10.9

2002

11.4

10.6

2001

2006

10.3

2000

11.5

10.4

1999

2005

TLE

Year

Table 2

6.7

6.8

6.7

6.5

6.4

6.1

6.2

6.2

6.2

6.2

6.4

6.4

6.3

6.2

6.3

DFLE

55.1 (53.3 - 56.9)

55.1 (53.2 - 57.1)

54.4 (52.4 - 56.4)

54.1 (52 - 56.2)

53.9 (51.7 - 56.1)

53.1 (50.7 - 55.4)

53.8 (51.5 - 56)

54.5 (52.3 - 56.8)

54.4 (52.2 - 56.6)

54.6 (52.4 - 56.7)

57.1 (55 - 59.1)

58.6 (56.5 - 60.7)

59.4 (57.3 - 61.6)

60.2 (58.1 - 62.3)

60.4 (58.3 - 62.5)

DFT (C.I. - / +)

White Males, ages 80+

12

12.1

11.9

11

10.5

10.4

9.9

9.9

9.8

9.6

9.3

9.4

9.2

9.2

9.4

TLE

6.6

6.5

6.0

5.5

5.2

4.9

4.8

5.0

5.3

5.7

5.5

5.4

5.2

4.9

4.3

DFLE

54.9 (49.5 - 60.4)

53.4 (47.9 - 58.9)

50.4 (44.8 - 55.9)

50.3 (44.5 - 56)

50 (43.8 - 56.1)

47.6 (41.2 - 54)

49 (42.4 - 55.5)

51 (44.4 - 57.6)

54.4 (47.8 - 61)

59.1 (52.6 - 65.5)

59.8 (53.5 - 66)

57.1 (50.6 - 63.5)

56.3 (49.6 - 63)

53 (46.4 - 59.5)

46.2 (39.7 - 52.7)

DFT (C.I. - / +)

Black Males, ages 80+

15.4

15.7

15.7

15.1

15.8

16.4

15.7

14

13.5

13

12.7

12.8

13.7

13.9

13.6

TLE

7.8

7.5

8.6

7.7

7.4

8.1

7.0

5.3

5.2

5.2

5.4

6.2

7.2

7.6

7.5

DFLE

51 (41.3 - 60.7)

47.8 (38.1 - 57.5)

54.8 (45.4 - 64.2)

51 (40.5 - 61.4)

46.9 (35.8 - 57.9)

49.3 (37.6 - 61)

44.8 (33 - 56.5)

38.2 (26.1 - 50.2)

38.3 (26.7 - 49.8)

40.1 (28.3 - 52)

42.5 (30.9 - 54.1)

48.4 (36.4 - 60.4)

52.4 (40.6 - 64.2)

54.5 (42.4 - 66.6)

55.1 (42.6 - 67.6)

DFT (C.I. - / +)

USB Hisp Males, ages 80+

15.8

15.7

15.9

16

15.9

15

14.9

14.9

14.7

13.9

13.4

13.4

13.2

13.4

13.8

TLE

6.8

6.5

7.0

6.4

6.5

7.0

7.6

6.7

7.1

7.2

6.1

6.0

6.3

6.9

7.4

DFLE

43.1 (35.7 - 50.6)

41.2 (33.3 - 49.1)

43.8 (35.6 - 52)

39.8 (31.6 - 48.1)

41 (32.4 - 49.6)

46.7 (37.1 - 56.2)

50.7 (41.3 - 60.2)

45.4 (35.6 - 55.2)

48.5 (38.9 - 58.1)

51.6 (41.8 - 61.4)

45.4 (36.1 - 54.7)

44.8 (35.1 - 54.4)

47.9 (38.1 - 57.6)

51.3 (41.1 - 61.5)

54.1 (44.6 - 63.7)

DFT (C.I. - / +)

FB Hisp Males, ages 80+

Total life expectancy, disability-free life expectancy, and percentage of life lived without disability by gender,
race-ethnicity, and nativity at ages 65-69, 1999-2013.

61

15.1

15

14.8

14.7

2010

2011

2012

2013

6.3

6.5

6.7

6.9

7.0

7.1

7.0

7.0

6.9

6.8

6.6

6.4

6.2

6.0

5.7

DFLE

42.8 (41.4 - 44.1)

44 (42.6 - 45.4)

44.5 (43 - 45.9)

45.4 (43.9 - 46.9)

45.9 (44.3 - 47.5)

47 (45.4 - 48.6)

46.8 (45.2 - 48.4)

46.9 (45.3 - 48.4)

47.4 (45.9 - 48.9)

47.9 (46.4 - 49.3)

47 (45.6 - 48.5)

47 (45.5 - 48.4)

46.1 (44.7 - 47.6)

44.9 (43.4 - 46.3)

43.1 (41.7 - 44.6)

DFT (C.I. - / +)

13.7

14

13.8

13.6

13.5

13.2

12.9

12.6

12.3

12

11.4

11

10.8

10.5

10.6

TLE

5.8

5.7

5.6

5.5

5.3

5.0

4.9

4.8

4.9

4.9

4.9

4.8

4.5

4.0

3.8

DFLE

42.3 (38.9 - 45.8)

40.8 (37.2 - 44.3)

40.5 (36.9 - 44)

40.1 (36.5 - 43.7)

39.2 (35.4 - 43)

37.7 (33.7 - 41.6)

38.4 (34.3 - 42.4)

38.4 (34.2 - 42.6)

39.8 (35.6 - 44.1)

41.2 (36.9 - 45.5)

42.8 (38.6 - 47.1)

43.4 (39.2 - 47.6)

41.4 (37.2 - 45.6)

38.4 (34.2 - 42.5)

35.9 (32 - 39.9)

DFT (C.I. - / +)

Black Females, ages 80+

16.8

16.8

16.9

16.8

16.5

17.4

17.8

17.7

17.7

17.9

17.3

16.5

15.5

15

14.4

TLE

6.1

7.0

7.3

7.6

7.7

8.3

7.6

7.4

6.8

7.1

6.7

6.9

6.1

6.1

5.3

DFLE

36 (29.4 - 42.5)

41.5 (34.6 - 48.3)

43.1 (35.8 - 50.4)

45.2 (37.4 - 53.1)

46.6 (38.2 - 54.9)

47.8 (38.7 - 57)

42.7 (34 - 51.4)

41.6 (33.1 - 50.1)

38.3 (30.1 - 46.6)

39.5 (31.2 - 47.9)

39 (31 - 47)

41.7 (33.4 - 50.1)

39.2 (30.9 - 47.5)

40.4 (32.1 - 48.8)

37 (28.7 - 45.3)

DFT (C.I. - / +)

USB Hisp Females, ages 80+

19.4

18.8

19.2

19.3

18.6

17.9

17.8

16.9

16.3

15.6

15

14.4

14.6

14.7

15

TLE

8.2

7.0

7.2

8.3

7.9

8.0

8.8

8.4

7.2

7.3

6.4

6.2

6.0

5.9

5.4

DFLE

42.3 (36.8 - 47.8)

37.5 (31.9 - 43.1)

37.5 (31.8 - 43.1)

42.9 (36.8 - 49.1)

42.5 (36 - 49)

44.3 (37.3 - 51.3)

49.6 (42.7 - 56.6)

49.6 (42.4 - 56.7)

44.1 (37.1 - 51)

46.9 (40 - 53.8)

43.1 (36.4 - 49.8)

43.2 (36.3 - 50.1)

41.4 (34.5 - 48.4)

40.2 (33.2 - 47.1)

36.1 (29.2 - 43.1)

DFT (C.I. - / +)

FB Hisp Females, ages 80+

NOTES: 95% confidence intervals in parentheses. TLE: total life expectancy. DFLE: disability-free life expectancy.
DFT: DFLE divided by TLE.
SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file, National Health Interview Survey

15.2

14.6

2005

2009

14.3

2004

15.2

14

2003

2008

13.6

2002

15.1

13.4

2001

2007

13.3

2000

14.9

13.3

1999

2006

TLE

Year

White Females, ages 80+

Table 2 (Continued)

62

20.30

20.50

20.70

21.00

21.00

21.00

2008

2009

2010

2011

2012

2013

19.70

2004

20.20

19.40

2003

2007

19.00

2002

20.10

18.60

2001

2006

18.30

2000

20.00

18.20

1999

2005

TLE

14.00

14.10

14.00

13.90

13.70

13.50

13.50

13.50

13.40

13.40

13.30

13.30

13.10

13.00

12.80

DFLE

66.7 (65.8 - 67.6)

66.9 (65.9 - 67.8)

66.6 (65.5 - 67.6)

66.9 (65.8 - 67.9)

66.5 (65.4 - 67.6)

66.6 (65.5 - 67.8)

66.8 (65.7 - 67.9)

67.2 (66.1 - 68.3)

67 (65.9 - 68)

68 (66.9 - 69)

68.9 (67.9 - 69.8)

69.9 (68.9 - 70.9)

70.6 (69.6 - 71.6)

71 (70.1 - 72)

70.5 (69.6 - 71.5)

DFT (C.I. - / +)

19.1

19.1

18.9

18.2

17.9

17.6

17.2

17

16.9

16.6

16.3

16.2

16

15.9

15.8

TLE

12.0

11.8

11.7

11.3

11.1

11.0

11.0

10.8

10.9

11.0

10.7

10.5

10.5

10.4

9.8

DFLE

63 (60.6 - 65.5)

62 (59.4 - 64.5)

62.2 (59.6 - 64.7)

62.3 (59.7 - 64.9)

62.2 (59.4 - 64.9)

62.5 (59.6 - 65.3)

63.6 (60.8 - 66.4)

63.6 (60.7 - 66.5)

64.4 (61.5 - 67.3)

66 (63.2 - 68.8)

65.6 (62.8 - 68.4)

64.9 (62 - 67.7)

65.6 (62.8 - 68.5)

65.1 (62.3 - 67.9)

62.4 (59.7 - 65.2)

DFT (C.I. - / +)

Black Males, ages 65-69

24.1

24.4

24.3

23.9

24.5

24.9

24.3

22.7

22.2

21.4

20.9

20.7

21.1

21.1

20.9

TLE

15.0

14.8

15.4

15.1

15.4

15.8

15.0

13.4

13.2

12.4

12.0

12.3

13.2

13.3

13.5

DFLE

62 (57.1 - 67)

60.6 (55.5 - 65.7)

63.3 (58.3 - 68.3)

63 (57.6 - 68.5)

62.7 (56.9 - 68.5)

63.6 (57.4 - 69.8)

61.8 (55.6 - 67.9)

58.9 (52.8 - 65)

59.2 (53.5 - 64.9)

57.7 (52 - 63.4)

57.5 (52.1 - 62.9)

59.6 (54.1 - 65)

62.7 (57.2 - 68.2)

63.3 (57.7 - 68.8)

64.6 (59 - 70.2)

DFT (C.I. - / +)

USB Hisp Males, ages 65-69

24.9

24.8

24.9

24.9

24.7

24

23.9

23.8

23.7

23.2

22.8

22.6

22.4

22.3

22.4

TLE

15.2

15.0

15.2

14.7

14.7

14.8

15.2

15.0

15.5

15.6

15.3

14.7

14.9

14.8

14.9

DFLE

60.9 (56.9 - 64.8)

60.4 (56.3 - 64.5)

61.1 (56.9 - 65.4)

58.8 (54.5 - 63.1)

59.7 (55.3 - 64.2)

61.6 (56.8 - 66.3)

63.6 (58.8 - 68.3)

62.8 (57.9 - 67.8)

65.3 (60.5 - 70)

67.4 (62.6 - 72.1)

67.2 (62.7 - 71.6)

65 (60.4 - 69.6)

66.7 (62.1 - 71.3)

66.6 (61.8 - 71.4)

66.7 (62.1 - 71.3)

DFT (C.I. - / +)

FB Hisp Males, ages 65-69

Total life expectancy, disability-free life expectancy, and percentage of life lived without disability by gender,
race-ethnicity, and nativity at ages 65-69, Unweighted prevalence, 1999-2013.

White Males, ages 65-69

Year

Table 3

63

25.1

25.1

25

24.9

2010

2011

2012

2013

13.7

13.8

13.9

13.9

14.0

14.1

14.1

14.0

14.0

13.8

13.6

13.5

13.4

13.2

12.9

DFLE

55.1 (54.4 - 55.9)

55.2 (54.4 - 56)

55.3 (54.4 - 56.1)

55.4 (54.5 - 56.3)

55.6 (54.7 - 56.5)

56.4 (55.5 - 57.4)

56.8 (55.8 - 57.7)

56.9 (55.9 - 57.8)

57.1 (56.2 - 58)

57.5 (56.6 - 58.3)

57.3 (56.5 - 58.2)

57.9 (57 - 58.7)

58.1 (57.3 - 58.9)

57.7 (56.9 - 58.5)

56.7 (55.9 - 57.5)

DFT (C.I. - / +)

22.7

22.8

22.6

22.4

22.2

21.9

21.6

21.3

21

20.6

20.1

19.7

19.4

19.1

19.1

TLE

11.3

11.3

11.5

11.5

11.4

11.2

10.9

10.5

10.3

10.2

10.2

10.1

9.8

9.6

9.4

DFLE

49.8 (47.9 - 51.7)

49.8 (47.9 - 51.7)

50.9 (49 - 52.9)

51.4 (49.3 - 53.4)

51.3 (49.2 - 53.4)

50.9 (48.7 - 53)

50.5 (48.3 - 52.7)

49.6 (47.3 - 51.8)

49 (46.8 - 51.3)

49.5 (47.2 - 51.7)

50.5 (48.3 - 52.7)

51.1 (48.9 - 53.2)

50.7 (48.5 - 52.8)

50.2 (48.1 - 52.4)

49 (47 - 51.1)

DFT (C.I. - / +)

Black Females, ages 65-69

27.5

27.5

27.6

27.4

27.2

27.9

28

27.8

27.7

27.7

27

26.2

25.3

24.7

24.1

TLE

13.4

13.7

14.0

14.3

14.4

15.7

15.1

14.3

13.7

13.9

13.0

13.2

13.0

12.8

11.8

DFLE

48.6 (44.8 - 52.5)

49.9 (45.8 - 53.9)

50.7 (46.5 - 55)

52.2 (47.7 - 56.8)

53.1 (48.3 - 57.9)

56.3 (51.1 - 61.5)

53.9 (48.9 - 58.9)

51.6 (46.7 - 56.5)

49.4 (44.6 - 54.1)

50.2 (45.5 - 55)

48.1 (43.6 - 52.6)

50.5 (46 - 55.1)

51.4 (47 - 55.8)

52 (47.6 - 56.3)

48.9 (44.6 - 53.2)

DFT (C.I. - / +)

USB Hisp Females, ages 65-69

30

29.5

29.7

29.8

29.2

28.6

28.4

27.4

26.8

26.1

25.5

25.1

25.2

25.4

25.6

TLE

14.9

14.4

14.3

15.4

15.5

15.6

16.1

15.9

14.6

14.3

14.0

13.8

13.9

13.9

13.8

DFLE

49.7 (46.5 - 52.9)

48.9 (45.6 - 52.2)

47.9 (44.6 - 51.3)

51.7 (48.1 - 55.3)

53.1 (49.4 - 56.9)

54.6 (50.6 - 58.6)

56.8 (52.8 - 60.8)

57.9 (53.9 - 61.8)

54.6 (50.8 - 58.5)

54.9 (51.1 - 58.6)

55.1 (51.6 - 58.7)

55 (51.4 - 58.7)

55 (51.3 - 58.6)

54.6 (51 - 58.3)

53.9 (50.1 - 57.6)

DFT (C.I. - / +)

FB Hisp Females, ages 65-69

NOTES: 95% confidence intervals in parentheses. TLE: total life expectancy. DFLE: disability-free life expectancy.
DFT: DFLE divided by TLE.
SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file, National Health Interview Survey

25.1

24.4

2005

2009

24.1

2004

25

23.7

2003

2008

23.4

2002

24.9

23

2001

2007

22.9

2000

24.7

22.8

1999

2006

TLE

Year

White Females, ages 65-69

Table 3 (Continued)

64

11.5

11.8

12

12.2

12.3

12.2

2008

2009

2010

2011

2012

2013

11.3

2004

11.5

11.2

2003

2007

10.9

2002

11.4

10.6

2001

2006

10.3

2000

11.5

10.4

1999

2005

TLE

Year

Table 4

6.8

6.8

6.8

6.6

6.5

6.3

6.3

6.4

6.3

6.3

6.4

6.4

6.3

6.2

6.2

DFLE

55.6 (53.7 - 57.4)

55.9 (53.9 - 57.8)

55.4 (53.4 - 57.4)

55.3 (53.2 - 57.4)

54.9 (52.7 - 57.1)

54.5 (52.1 - 56.8)

54.9 (52.6 - 57.1)

55.6 (53.4 - 57.9)

55.1 (52.9 - 57.2)

55.9 (53.8 - 58)

57.6 (55.5 - 59.7)

59.3 (57.2 - 61.4)

59.8 (57.7 - 62)

60.3 (58.1 - 62.4)

59.9 (57.8 - 62)

DFT (C.I. - / +)

White Males, ages 80+

12

12.1

11.9

11

10.5

10.4

9.9

9.9

9.8

9.6

9.3

9.4

9.2

9.2

9.4

TLE

6.4

6.5

6.5

5.8

5.4

5.1

4.9

4.7

5.1

5.5

5.4

5.3

5.3

5.0

4.5

DFLE

53.3 (47.9 - 58.8)

53.5 (48 - 59)

54.3 (48.8 - 59.8)

52.5 (46.8 - 58.3)

51.2 (45.1 - 57.4)

49.1 (42.7 - 55.5)

49.4 (42.9 - 55.9)

48.2 (41.5 - 54.8)

52.1 (45.5 - 58.7)

57 (50.5 - 63.4)

58 (51.8 - 64.3)

56.4 (49.9 - 62.8)

57.5 (50.8 - 64.2)

53.9 (47.4 - 60.5)

47.7 (41.2 - 54.2)

DFT (C.I. - / +)

Black Males, ages 80+

15.4

15.7

15.7

15.1

15.8

16.4

15.7

14

13.5

13

12.7

12.8

13.7

13.9

13.6

TLE

7.9

7.7

8.4

8.3

8.0

9.0

7.9

6.2

5.6

5.5

5.2

5.8

6.7

7.2

7.2

DFLE

51.5 (41.8 - 61.1)

49.2 (39.5 - 58.9)

53.7 (44.3 - 63.1)

55 (44.6 - 65.4)

50.5 (39.4 - 61.6)

54.8 (43.1 - 66.5)

50.3 (38.5 - 62.1)

44.7 (32.3 - 57)

41.3 (29.6 - 53)

42.5 (30.6 - 54.4)

40.6 (29.1 - 52.1)

45.1 (33.2 - 57.1)

48.9 (37.1 - 60.7)

51.4 (39.3 - 63.6)

53.1 (40.6 - 65.6)

DFT (C.I. - / +)

USB Hisp Males, ages 80+

15.8

15.7

15.9

16

15.9

15

14.9

14.9

14.7

13.9

13.4

13.4

13.2

13.4

13.8

TLE

7.5

7.1

7.3

6.6

6.6

6.9

7.5

7.4

7.6

7.7

6.9

6.2

6.4

6.8

7.4

DFLE

47.6 (40 - 55.1)

45.3 (37.3 - 53.3)

46 (37.7 - 54.2)

41.3 (33 - 49.6)

41.4 (32.8 - 50)

45.7 (36.1 - 55.2)

50.2 (40.7 - 59.6)

49.7 (39.8 - 59.5)

51.9 (42.3 - 61.5)

55.1 (45.4 - 64.9)

51.4 (42.1 - 60.7)

46.5 (36.8 - 56.2)

48.6 (38.8 - 58.4)

50.9 (40.7 - 61.1)

53.5 (44 - 63.1)

DFT (C.I. - / +)

FB Hisp Males, ages 80+

Total life expectancy, disability-free life expectancy, and percentage of life lived without disability by gender,
race-ethnicity, and nativity at ages 80+, Unweighted prevalence, 1999-2013.

65

15.1

15

14.8

14.7

2010

2011

2012

2013

6.4

6.6

6.7

6.9

7.0

7.2

7.2

7.1

7.0

6.9

6.6

6.4

6.2

6.0

5.7

DFLE

43.4 (42 - 44.8)

44.2 (42.8 - 45.6)

44.6 (43.2 - 46.1)

45.3 (43.8 - 46.8)

46.2 (44.7 - 47.8)

47.2 (45.6 - 48.9)

47.6 (46 - 49.2)

47.9 (46.3 - 49.4)

48.1 (46.6 - 49.6)

48.3 (46.8 - 49.7)

47.4 (46 - 48.8)

47.1 (45.7 - 48.6)

46.2 (44.8 - 47.7)

45.2 (43.7 - 46.7)

43.2 (41.8 - 44.7)

DFT (C.I. - / +)

13.7

14

13.8

13.6

13.5

13.2

12.9

12.6

12.3

12

11.4

11

10.8

10.5

10.6

TLE

5.7

5.7

5.8

5.7

5.5

5.4

5.2

5.0

5.0

5.1

4.9

4.8

4.5

4.2

3.8

DFLE

41.7 (38.2 - 45.1)

41 (37.5 - 44.5)

42.1 (38.5 - 45.7)

42.2 (38.5 - 45.8)

41.2 (37.4 - 45)

40.8 (36.8 - 44.8)

40.7 (36.6 - 44.8)

39.8 (35.6 - 44)

40.8 (36.5 - 45.1)

42.3 (37.9 - 46.6)

43.1 (38.9 - 47.4)

43.6 (39.4 - 47.7)

41.7 (37.6 - 45.9)

39.5 (35.4 - 43.7)

35.9 (32 - 39.9)

DFT (C.I. - / +)

Black Females, ages 80+

16.8

16.8

16.9

16.8

16.5

17.4

17.8

17.7

17.7

17.9

17.3

16.5

15.5

15

14.4

TLE

6.3

7.0

7.0

6.6

6.7

7.5

6.6

6.3

6.6

6.6

6.5

7.1

6.9

6.8

6.4

DFLE

37.5 (30.9 - 44.2)

41.5 (34.7 - 48.4)

41.6 (34.3 - 48.9)

39.5 (31.8 - 47.2)

40.6 (32.4 - 48.8)

42.7 (33.7 - 51.8)

37 (28.4 - 45.5)

35.8 (27.5 - 44)

37.4 (29.1 - 45.6)

36.9 (28.6 - 45.2)

37.4 (29.5 - 45.4)

42.8 (34.4 - 51.1)

44.1 (35.7 - 52.5)

45.1 (36.7 - 53.5)

44.2 (35.7 - 52.7)

DFT (C.I. - / +)

USB Hisp Females, ages 80+

19.4

18.8

19.2

19.3

18.6

17.9

17.8

16.9

16.3

15.6

15

14.4

14.6

14.7

15

TLE

8.1

7.3

7.2

8.3

8.3

8.5

9.0

8.8

7.6

7.2

6.5

6.3

6.2

6.0

5.8

DFLE

41.6 (36.1 - 47)

38.8 (33.2 - 44.5)

37.6 (31.9 - 43.3)

43 (36.9 - 49.2)

44.4 (37.9 - 51)

47.3 (40.3 - 54.3)

50.7 (43.7 - 57.7)

51.9 (44.8 - 59)

46.6 (39.6 - 53.5)

46.4 (39.4 - 53.3)

43.6 (36.9 - 50.3)

43.8 (36.9 - 50.8)

42.3 (35.4 - 49.3)

40.8 (33.8 - 47.8)

39 (31.9 - 46)

DFT (C.I. - / +)

FB Hisp Females, ages 80+

NOTES: 95% confidence intervals in parentheses. TLE: total life expectancy. DFLE: disability-free life expectancy.
DFT: DFLE divided by TLE.
SOURCES: 1997-2015 Current Population Survey, Multiple Cause of Death file, National Health Interview Survey
Hidden test to allow template to find last page in document

15.2

14.6

2005

2009

14.3

2004

15.2

14

2003

2008

13.6

2002

15.1

13.4

2001

2007

13.3

2000

14.9

13.3

1999

2006

TLE

Year

White Females, ages 80+

Table 4 (Continued)

